1. Home
  2. PERI vs BWAY Comparison

PERI vs BWAY Comparison

Compare PERI & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

HOLD

Current Price

$10.30

Market Cap

412.5M

Sector

Technology

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$15.81

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
BWAY
Founded
1999
2003
Country
Israel
Israel
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
412.5M
450.8M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
PERI
BWAY
Price
$10.30
$15.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$14.50
$13.25
AVG Volume (30 Days)
344.5K
167.5K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.98
$309.69
Revenue Next Year
$2.48
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$8.07
$7.84
52 Week High
$11.44
$26.63

Technical Indicators

Market Signals
Indicator
PERI
BWAY
Relative Strength Index (RSI) 66.31 56.49
Support Level $9.14 $14.56
Resistance Level $10.25 $16.63
Average True Range (ATR) 0.37 0.75
MACD -0.01 0.56
Stochastic Oscillator 77.48 89.05

Price Performance

Historical Comparison
PERI
BWAY

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: